ClinicalTrials.govpublic full text
The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer Patients
thrombocytopenia, niraparib, hetrombopag, primary prevention, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1032321
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.